These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27263421)

  • 1. Oral health in patients taking psychotropic medications: Results from a pharmacy-based pilot study.
    Heaton LJ; Swigart K; McNelis G; Milgrom P; Downing DF
    J Am Pharm Assoc (2003); 2016; 56(4):412-417.e1. PubMed ID: 27263421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supporting patients with mental illness: Deconstructing barriers to community pharmacist access.
    Calogero S; Caley CF
    J Am Pharm Assoc (2003); 2017; 57(2):248-255. PubMed ID: 28153705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Describing the role of Australian community pharmacists in oral healthcare.
    Taing MW; Ford PJ; Gartner CE; Freeman CR
    Int J Pharm Pract; 2016 Aug; 24(4):237-46. PubMed ID: 26809378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of community pharmacists as oral health advisors in the management of oral effects of asthma medications: an exploratory survey.
    Ho AVL; Lau I; Davidson M; Nimmo A; Croker FA
    Int J Pharm Pract; 2024 Jul; 32(4):280-286. PubMed ID: 38738298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot workshop to help refugees navigate the U.S. pharmacy system.
    Goldsmith CA; Abel C; Yu S
    J Am Pharm Assoc (2003); 2016; 56(4):461-466.e1. PubMed ID: 27090560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From personal crisis care to convenience shopping: an interpretive description of the experiences of people with mental illness and addictions in community pharmacies.
    Murphy AL; Martin-Misener R; Kutcher SP; O'Reilly CL; Chen TF; Gardner DM
    BMC Health Serv Res; 2016 Oct; 16(1):569. PubMed ID: 27729051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community pharmacy and pharmacist staff call center: assessment of medication safety and effectiveness.
    Higgins L; Brown M; Murphy JE; Malone DC; Armstrong EP; Woosley RL
    J Am Pharm Assoc (2003); 2011; 51(1):82-9. PubMed ID: 21247830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral health of patients on psychotropic medications: a study of outpatients in Queensland.
    Lalloo R; Kisely S; Amarasinghe H; Perera R; Johnson N
    Australas Psychiatry; 2013 Aug; 21(4):338-42. PubMed ID: 23671224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacy performance while providing continuous medication monitoring.
    Doucette WR; McDonough RP; Herald F; Goedken A; Funk J; Deninger MJ
    J Am Pharm Assoc (2003); 2017; 57(6):692-697. PubMed ID: 28844583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring oral healthcare management across Australian community pharmacies using case vignettes.
    Taing MW; Firth N; Ford PJ; Freeman CR
    Community Dent Oral Epidemiol; 2019 Jun; 47(3):225-235. PubMed ID: 30734359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hmong adults self-rated oral health: a pilot study.
    Okunseri C; Yang M; Gonzalez C; LeMay W; Iacopino AM
    J Immigr Minor Health; 2008 Feb; 10(1):81-8. PubMed ID: 17546502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing and testing evidence-based weight management in Australian pharmacies: A Healthier Life Program.
    Um IS; Krass I; Armour C; Gill T; Chaar BB
    Int J Clin Pharm; 2015 Oct; 37(5):822-33. PubMed ID: 25920908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of overlapping prescriptions of psychotropic drugs by community pharmacists.
    Shimane T; Matsumoto T; Wada K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2012 Oct; 47(5):202-10. PubMed ID: 23393998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can a pharmacy intervention improve the metabolic risks of mental health patients? Evaluation of a novel collaborative service.
    Maulavizada H; Emmerton L; Hattingh HL
    BMC Health Serv Res; 2016 Apr; 16():146. PubMed ID: 27112344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Health Status of Independent Older Adults in Texas: An observational study comparing urban and rural areas.
    Martin JL; Boyd LD; Tapias-Perdigón H; LaSpina LM
    J Dent Hyg; 2017 Oct; 91(5):40-47. PubMed ID: 29118278
    [No Abstract]   [Full Text] [Related]  

  • 19. Association between community pharmacy loyalty and persistence and implementation of antipsychotic treatment among individuals with schizophrenia.
    Zongo FE; Moisan J; Grégoire JP; Lesage A; Dossa AR; Lauzier S
    Res Social Adm Pharm; 2018 Jan; 14(1):53-61. PubMed ID: 28077240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient care activities by community pharmacists in a capitation funding model mental health and addictions program.
    Murphy AL; Gardner DM; Jacobs LM
    BMC Psychiatry; 2018 Jun; 18(1):192. PubMed ID: 29898682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.